CITRYLL PRESENTS POSITIVE DATA FROM PHASE I STUDY OF CIT-013 IN RHEUMATOID ARTHRITIS AT ACR CONVERGENCE 2025. Phase I trial data in rheumatoid arthritis patients demonstrates favo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback